Table 4 Univariate and multivariate disease specific survival analysis in 170 patients with invasive vulvar cancer.

From: Prognostic value of serum creatine level in patients with vulvar cancer

Parameter

univariate

multivariate

3-ys DSS

p-value

Comparison

HR

95%-CI

p-value

Serum Creatinine

 

<0.001

>vs. ≤ 1.2 mg/dl

3.8

1.6–9.0

0.002

   ≤1.20

85.1%

     

   >1.20

42.8%

     

Serum Creatinine

 

0.005

    

FIGO tumor stage

 

<0.001

I vs. II vs. III vs. IV

2.0

1.5–2.8

<0.001

   FIGO I

93.6%

     

   FIGO II

59.9%

     

   FIGO III

63.1%

     

   FIGO IV

72.5%

     

Age

 

0.014

>vs. ≤ 67.7 years

2.3

1.0–5.0

0.038

   ≤67.7

86.7%

     

   >67.7

76.5%

     

Grading

 

0.07

    

   G1

89.2%

     

   G2/3

78.6%

     

Nodal involvement

 

<0.001

    

   N0

92.1%

     

   N1

60.7%

     
  1. FIGO International Federation of Gynecologists and Obstetrics, DSS disease specific survival, HR hazard ratio, CI confidence interval.
  2. Nodal involvement was not included into the multivariate model, since the nodal status is a crucial part of FIGO stage.
Back to article page